close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Strona główna・Stock List・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Closed

SectorHealthcare

17.01 1.19

Buy

Price update 11 gru 2025, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

16.64

Max

17.26

Key metrics

By Trading Economics

Income

28M

8.2M

Sales

351K

351K

P/E

Sector Avg

19.523

77.671

EPS

0.94

Profit margin

2,337.322

Employees

103

EBITDA

28M

9.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+29.56% upside

Market Stats

By TradingEconomics

Market Cap

22M

155M

Previous open

15.82

Previous close

17.01

News Sentiment

By Acuity

67%

33%

335 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.31 Support & Resistance

Seres Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 gru 2025, 23:58 UTC

Acquisitions, Mergers, Takeovers

Destination XL to Merge With Oaktree-Backed Fullbeauty Brands -- Update

DJ

Read

11 gru 2025, 23:56 UTC

Earnings

Costco Logs Higher Sales, Eyes Expansion to Fuel Membership Growth -- Update

DJ

Read

11 gru 2025, 23:03 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725 Million Acquisition of Liquid Nails From PE Firm

DJ

Read

11 gru 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

Scentre to Sell $456 Million Westfield Chermside Mall Stake to Dexus-Managed Fund

DJ

Read

11 gru 2025, 21:50 UTC

Earnings

Costco Same-Store Sales, Membership Fees Rose in 1Q

DJ

Read

11 gru 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

11 gru 2025, 23:44 UTC

Market Talk

Nikkei May Rise After U.S. Stock Indexes Hit Record Highs -- Market Talk

DJ

Read

11 gru 2025, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Dollar's Weakness -- Market Talk

DJ

Read

11 gru 2025, 23:31 UTC

Earnings

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

DJ

Read

11 gru 2025, 22:48 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725M Acquisition of Liquid Nails From PE Firm

DJ

Read

11 gru 2025, 22:35 UTC

Earnings

Costco Sold 4.5 Million Pies Ahead of Thanksgiving. Despite Earnings Beat, the Stock Fails to Gain Traction. -- Barrons.com

DJ

Read

11 gru 2025, 22:30 UTC

Earnings

Broadcom Beats Earnings. The Stock Wavers After Customer Updates. -- Barrons.com

DJ

Read

11 gru 2025, 22:09 UTC

Acquisitions, Mergers, Takeovers

FTC Alleges Henkel Deal Would Combine Two Biggest Brands of Construction Adhesives Sold at Stores Like Home Depot, Leading to Higher Prices

DJ

Read

11 gru 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel From Buying Loctite Competitor Liquid Nails

DJ

Read

11 gru 2025, 22:05 UTC

Earnings

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

DJ

Read

11 gru 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Scentre to Sell $456M Westfield Chermside Mall Stake to Dexus-Managed Fund

DJ

Read

11 gru 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

11 gru 2025, 21:39 UTC

Earnings

Broadcom Beats Earnings. The Stock Rises. -- Barrons.com

DJ

Read

11 gru 2025, 21:39 UTC

Earnings

Broadcom Reports $18 Billion in Revenue as AI Chip Sales Climb -- WSJ

DJ

Read

11 gru 2025, 21:38 UTC

Earnings

Costco Tops Earnings Estimates but Stock Fails to Gain Traction -- Barrons.com

DJ

Read

11 gru 2025, 21:37 UTC

Earnings

These Stocks Moved the Most Today: Oracle, Nvidia, Broadcom, Planet Labs, Visa, Ciena, Gemini Space Station, and More -- Barrons.com

DJ

Read

11 gru 2025, 21:37 UTC

Market Talk

Broadcom Sees AI Revenue Doubling -- Market Talk

DJ

Read

11 gru 2025, 21:34 UTC

Acquisitions, Mergers, Takeovers

Scentre Will Temporarily Invest A$50M in the New Dexus Fund

DJ

Read

11 gru 2025, 21:29 UTC

Acquisitions, Mergers, Takeovers

Dexus Aiming for Long-Term Holding of A$50M in Fund

DJ

Read

11 gru 2025, 21:28 UTC

Market Talk

BLS Publishing Calendar Delays Now Pushing Economic Data Into February -- Market Talk

DJ

Read

11 gru 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Dexus Expects to Introduce Additional Third-Party Equity in FY26

DJ

Read

11 gru 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Dexus: Third Party Investors to Contribute Remainder

DJ

Read

11 gru 2025, 21:27 UTC

Acquisitions, Mergers, Takeovers

Dexus to Put Initial A$170M into New Dexus Strategic Investment Trust

DJ

Read

11 gru 2025, 21:26 UTC

Acquisitions, Mergers, Takeovers

Scentre: Dexus Wholesale Shopping Centre Fund Already Holds 25% Stake

DJ

Read

11 gru 2025, 21:25 UTC

Acquisitions, Mergers, Takeovers

Scentre: Purchase Price Represents Book Value, 5% Value Cap Rate

DJ

Read

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

29.56% upside

12 Months Forecast

Average 22 USD  29.56%

High 22 USD

Low 22 USD

Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Based on 2 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

335 / 374 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,006.06

↑ +1.27%

JNJ

Johnson and Johnson

209.91

↑ +1.6%

ABBV

AbbVie Inc

223.8

↓-0.55%

UNH

UnitedHealth Group Inc

336.55

↑ +2.68%

AZN

AstraZeneca PLC ADR

90.26

↓-1.28%
help-icon Live chat